Nuwellis Inc (NUWE): Market Cap to Revenue

Symbol and logo of brand Nuwellis Inc (NUWE)

Risks are associated with basic emission controls and the processing of defective products. The revenue valuation of Nuwellis, Inc. (NUWE) demonstrates a support level, where the value 0.30 describes the current level. The sale of high-margin blood filtration consumables ensures stability, while robotic assembly of units minimizes the impact of human error on product quality.

NUWE Nuwellis Inc P/S Multiple (07/04/2022 - 11/16/2026)

Analytical breakdowns for nuwellis.com (NUWE)

- share price and consensus valuation forecast:
- stock exchange capitalization data:
General company analysis:NUWE Nuwellis Inc
Core merchandise of Nuwellis, Inc.

The P/S business valuation for Nuwellis, Inc. (NUWE) reflects the market value of each unit of revenue generated from ultrafiltration system sales within the context of management's drive toward operational profitability. This ratio compares total market capitalization to annual sales volume, allowing investors to determine the asset's degree of overvaluation and assess correction risks during shifts in economic cycles.

Competitors of Nuwellis, Inc.

DXCM (DexCom Inc) - Market Capitalization-to-Revenue Ratio|P/S Multiple PEN (penumbrainc.com)|NOVT - Market Cap to Revenue|Haemonetics - P/S Multiple|Price to Sales Inspire Medical Systems|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Medical) - P/S Multiple|InMode Corp (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics, Inc. SRDX|P/S Multiple SENS (senseonics.com)|P/S Multiple NeuroPace Inc NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|Outset Medical Corp (OM) - Price-to-Revenue Ratio|SmartVest - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR Inc) - P/S Multiple|Price to Sales AVITA Medical Inc. RCEL|Price-to-Revenue Ratio Profound Medical (PROF)|Baird Medical Corp (BDMD) - Price-to-Revenue Multiple|EDAP TMS SA - Market Cap to Revenue|P/S Multiple Bovie Medical APYX|IceCure Medical Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx LUNG|TELA Bio (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corp.)|Price-to-Revenue Ratio sensushealthcare.com|Market Cap to Revenue Zynex, Inc. (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio inspira-technologies.com IINN|Market Cap to Sales Volume ICU (SeaStar Medical Holding Corp.)|IRIX: Market Cap to Revenue|ibs.inc - Market Cap to Sales Volume|XAIR: P/S Multiple|Price-to-Sales Ratio PFSA (Profusa Inc.)|Market Cap to Revenue SSKN|Price-to-Revenue Ratio GCTK|Price-to-Revenue Ratio NanoVibronix (NAOV)|Venus Concept - Market Cap to Revenue Ratio|P/S Multiple AEMD (Aethlon Medical, Inc.)|ASXC: Market Cap to Revenue Ratio|Avinger Inc. - P/S Multiple|Price-to-Revenue Coefficient BioSig Technologies, Inc BSGM|CUTR: P/S Multiple|Know Labs, Inc. (KNW) - P/S Multiple|Price-to-Revenue Ratio Inari Medical Inc|Market Cap to Revenue Nevro Corp (NVRO)|Market Cap to Revenue RSLS (ReShape Lifesciences, Inc.)|P/S Multiple Silk Road Medical Inc. (SILK)